ORCID as entered in ROS

Select Publications
2016, 'Prescribing and Dispensing of Benzodiazepines: Implications for Dependence and Misuse', in Neuropathology of Drug Addictions and Substance Misuse, pp. 283 - 292, http://dx.doi.org/10.1016/B978-0-12-800634-4.00028-7
,2016, 'Chapter 28 Prescribing and Dispensing of Benzodiazepines Implications for Dependence and Misuse', in Neuropathology of Drug Addictions and Substance Misuse, Elsevier, pp. 283 - 292, http://dx.doi.org/10.1016/b978-0-12-800634-4.00028-7
,2025, 'Australian general practitioners’ knowledge, attitudes and prescribing intentions for e-cigarettes as a smoking cessation aid_ a nationwide baseline and 12-month follow up survey', Harm Reduction Journal, 22, http://dx.doi.org/10.1186/s12954-025-01175-2
,2025, 'Medicines used in the treatment of opioid dependence', Australian Prescriber, 48, pp. 98 - 105, http://dx.doi.org/10.18773/austprescr.2025.028
,2025, '“The Whole Structure Is Knackered, It Could Still Explode, It Really Could”: A Mixed Methods Study of Initiatives to Increase General Practitioner Prescribing in an Opioid Dependence Treatment Program from 1970 to 2022 in New South Wales, Australia', Contemporary Drug Problems, 52, pp. 00914509241309109 - 00914509241309109, http://dx.doi.org/10.1177/00914509241309109
,2024, '‘Why do we have to be the gatekeepers?’ Australian general practitioners’ knowledge, attitudes and prescribing intentions on e-cigarettes as a smoking cessation aid', BMC Primary Care, 25, http://dx.doi.org/10.1186/s12875-024-02292-w
,2024, 'Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour', BMC Primary Care, 25, pp. 236 - 236, http://dx.doi.org/10.1186/s12875-024-02474-6
,2024, 'Assisting young people aged 12-25 years to cease e-cigarette use in general practice', Australian Journal of General Practice, 53, pp. 311 - 316, http://dx.doi.org/10.31128/AJGP-11-23-7021
,2023, 'Behavioural addictions Problem gambling in general practice: How can we help?', Australian Journal of General Practice, 52, pp. 289 - 294, http://dx.doi.org/10.31128/AJGP-06-22-6472
,2022, 'Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners’ experience', Australian Journal of General Practice, 51, pp. 804 - 811, http://dx.doi.org/10.31128/AJGP-10-21-6201
,2022, 'Real-time prescription monitoring How it can help safe prescribing of high-risk medicines', Medicine Today, 23, pp. 63 - 69
,2022, 'Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia', Australian Journal of General Practice, 51, pp. 447 - 451, http://dx.doi.org/10.31128/AJGP-07-21-6098
,2022, 'Feasibility and outcomes of a general practice and specialist alcohol and other drug collaborative care program in Sydney, Australia', Australian Journal of Primary Health, 28, pp. 158 - 163, http://dx.doi.org/10.1071/PY20197
,2022, 'What do General Practitioners want from Specialist Alcohol and Other Drugs Services? A Qualitative Study of NSW Metropolitan GPs', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13463
,2022, 'What do General Practitioners want from Specialist Alcohol and Other Drugs Services? A Qualitative Study of NSW Metropolitan GPs', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13463
,2021, 'Managing opioid withdrawal precipitated by buprenorphine with buprenorphine', Drug and Alcohol Review, 40, pp. 567 - 571, http://dx.doi.org/10.1111/dar.13228
,2021, 'The challenges of managing both chronic pain and opioid use in general practice', Medical Journal of Australia, 214, pp. 416 - 417, http://dx.doi.org/10.5694/mja2.51041
,2021, 'Letters', Australian Journal of General Practice, 50, pp. 7 - 8
,2021, 'Role legitimacy, comfort and confidence providing tobacco, alcohol and other drug care: a cross-sectional study of Australian early-career general practitioners', Education for Primary Care, 32, pp. 19 - 26, http://dx.doi.org/10.1080/14739879.2020.1830720
,2020, 'Opioid prescribing: What do the 2020 PBS changes mean for GPs?', Medicine Today, 21, pp. 21 - 28
,2020, 'Take-home intranasal naloxone to prevent opioid overdose deaths', Medicine Today, 21, pp. 45 - 49, https://medicinetoday.com.au/2020/april/regular-series/take-home-intranasal-naloxone-prevent-opioid-overdose-deaths
,2020, 'How stigmatising language affects people in Australia who use tobacco, alcohol and other drugs', Australian Journal of General Practice, 49, pp. 155 - 158, http://dx.doi.org/10.31128/AJGP-07-19-4998
,2018, 'Stigmatising language', AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 47, pp. 742 - 742, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000456317700003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Codeine rescheduling and the GP', Medicine Today, 19, pp. 17 - 26
,2018, 'A man taking large codeine doses who wants to cease: A buprenorphine–naloxone taper', Medicine Today, 19, pp. 33 - 34
,2004, 'Withdrawal of temazepam gelcaps', Australian Prescriber, 27, pp. 109 - 113, http://dx.doi.org/10.18773/austprescr.2004.089
,2004, 'Temazepam capsules: what was the problem?', Australian Prescriber, 27, pp. 58 - 59, http://dx.doi.org/10.18773/austprescr.2004.053
,2022, 'Perceptions of Australian general practitioners on e-cigarettes as a smoking cessation aid', in 01.03 - General practice and primary care, European Respiratory Society, pp. 2004 - 2004, presented at ERS International Congress 2022 abstracts, http://dx.doi.org/10.1183/13993003.congress-2022.2004
,2022, 'Diagnosing and managing prescription Opioid Use Disorder in patients prescribed opioids for chronic pain: Australian general practitioners' salient beliefs, social norms and perceived behavioural controls', in AUSTRALIAN JOURNAL OF PRIMARY HEALTH, CSIRO PUBLISHING, pp. LXVI - LXVI
,2016, 'EVALUATION OF A GENERAL PRACTITIONER AND DRUG AND ALCOHOL SHARED CARE PROGRAM USING HEALTH OUTCOMES OF CLIENTS IN SOUTH EASTERN SYDNEY, AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 76 - 76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'THE ESTABLISHMENT AND EVALUATION OF A PILOT SHARED CARE PROGRAM BETWEEN A PUBLIC SPECIALIST DRUG AND ALCOHOL SERVICE AND GENERAL PRACTICE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'THE ESTABLISHMENT AND EVALUATION OF A PILOT SHARED CARE PROGRAM BETWEEN GENERAL PRACTICE AND PUBLIC OTP SERVICES', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 90 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700279&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Prescription opioid use disorder in patients prescribed opioids for chronic pain: A diagnostic challenge for Australian general practitioners', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S149 - S150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'DEPOT BUPRENORPHINE TREATMENT IN PREGNANCY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S132 - S132, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'EXPERIENCES AND OUTCOMES OF DEPOT BUPRENORPHINE TREATMENT IN CLIENTS WITH CONCURRENT OPIOID DEPENDENCE AND CHRONIC PAIN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S65 - S65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, ‘Why do we have to be the gatekeepers?’ Australian general practitioner’s knowledge, attitudes and prescribing intentions on e-cigarettes as a smoking cessation aid, http://dx.doi.org/10.21203/rs.3.rs-2699952/v1
,